| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |